Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Feb 5;20(2):293–302.e9. doi: 10.1016/j.cgh.2021.02.010

Table 2.

Contributing factors to each endoscopic phenotype of the J pouch (multivariable analysis)

Phenotype N Variables Odds ratio (95% CI) P-value
Afferent limb involvement 131 BMI ≥ 25 1.84 (1.11–3.03) 0.017
Hand-sewn anastomosis 1.96 (1.15–3.33) 0.013
Inlet involvement 178 Male 1.58 (1.05–2.38) 0.028
Age at diagnosis ≥ 18 years old 0.58 (0.33–1.04) 0.068
Age at colectomy ≥ 18 years old 0.52 (0.22–1.21) 0.13
Diffuse inflammation of the pouch body 118 Disease extent E3 2.40 (1.02–5.66) 0.045
Preoperative anti-TNFα drugs 1.79 (1.08–2.97) 0.023
Family history of IBD 0.67 (0.38–1.20) 0.18
Age at diagnosis ≥ 18 years old 0.62 (0.34–1.12) 0.11
Male 1.55 (0.92–2.61) 0.10
Focal inflammation of the pouch body 218 Disease extent E3 0.52 (0.27–0.98) 0.044
Age at diagnosis ≥ 18 years old 1.40 (0.82–2.39) 0.22
Preoperative immunomodulators 1.39 (0.89–2.18) 0.15
Cuffitis 192 Stapled anastomosis 2.59 (1.28–5.22) 0.008
Preoperative CDI 2.06 (1.09–3.89) 0.025
3-stage IPAA 1.50 (0.83–2.70) 0.18
Dysplasia/Cancer (Indication of surgery) 0.78 (0.31–1.96) 0.59
Preoperative anti-TNFα drugs 1.42 (0.81–2.47) 0.22
Caucasian 0.46 (0.19–1.09) 0.076
Male 1.51 (0.90–2.51) 0.12
Fistulas 78 Preoperative diagnosis of Crohn’s disease 10.4 (1.81–60.0) 0.009
Family history of IBD 1.54 (0.90–2.64) 0.12
Preoperative anti-TNFα drugs 0.63 (0.37–1.07) 0.085